Kestra Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $821K | Sell |
10,497
-1,043
| -9% | -$81.6K | ﹤0.01% | 1613 |
|
|
2025
Q1 | $836K | Sell |
11,540
-754
| -6% | -$54.7K | ﹤0.01% | 1493 |
|
|
2024
Q4 | $910K | Sell |
12,294
-4,186
| -25% | -$310K | 0.01% | 1473 |
|
|
2024
Q3 | $1.09M | Sell |
16,480
-6,491
| -28% | -$428K | 0.01% | 1271 |
|
|
2024
Q2 | $2.12M | Buy |
22,971
+1,235
| +6% | +$114K | 0.01% | 932 |
|
|
2024
Q1 | $2.08M | Buy |
21,736
+1,389
| +7% | +$133K | 0.01% | 860 |
|
|
2023
Q4 | $1.55M | Buy |
20,347
+166
| +0.8% | +$12.7K | 0.01% | 918 |
|
|
2023
Q3 | $1.4M | Buy |
20,181
+4,201
| +26% | +$291K | 0.01% | 841 |
|
|
2023
Q2 | $1.51M | Sell |
15,980
-2,448
| -13% | -$231K | 0.02% | 795 |
|
|
2023
Q1 | $1.52M | Sell |
18,428
-22,040
| -54% | -$1.82M | 0.02% | 750 |
|
|
2022
Q4 | $3.02M | Buy |
40,468
+4,927
| +14% | +$368K | 0.03% | 591 |
|
|
2022
Q3 | $2.94M | Buy |
35,541
+6,436
| +22% | +$532K | 0.03% | 531 |
|
|
2022
Q2 | $2.77M | Buy |
29,105
+5,366
| +23% | +$510K | 0.03% | 549 |
|
|
2022
Q1 | $2.8M | Buy |
23,739
+1,348
| +6% | +$159K | 0.03% | 560 |
|
|
2021
Q4 | $2.9M | Sell |
22,391
-1,205
| -5% | -$156K | 0.03% | 557 |
|
|
2021
Q3 | $2.67M | Buy |
23,596
+1,390
| +6% | +$157K | 0.03% | 594 |
|
|
2021
Q2 | $2.3M | Sell |
22,206
-60
| -0.3% | -$6.22K | 0.03% | 594 |
|
|
2021
Q1 | $1.86M | Buy |
22,266
+10,232
| +85% | +$856K | 0.02% | 630 |
|
|
2020
Q4 | $1.08M | Buy |
12,034
+11,913
| +9,845% | +$1.07M | 0.01% | 839 |
|
|
2020
Q3 | $655K | Buy |
+121
| New | +$655K | 0.01% | 768 |
|